Institute of Formal and Applied Linguistics Wiki

CB: Moleculon Inc. acquired Kalipharma for $23 million its affiliate FH Faulding & Co., an Australian pharmaceutical company said. Kalipharma, a New Jersey-based pharmaceutical company, sells purepac label products. Faulding said it owns 33% of Moleculon's voting stock and has an agreement to acquire an additional 19%. That stake in preferred convertible stock holdings gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.

CW: Australian pharmaceutical company, F.H. Faulding & Company, said its affiliate, Moleculon Inc. has acquired Kalipharma Inc. for $23 million. Kalipharma, a New Jersey-based pharmaceutical concern, sells its various products under the Purepac label. Faulding said it owns 33% of Moleculon's voting stock and has the agreement to acquire an additional 19%. That stake, associated with convertible, preferred stock holdings, gives Faulding the right to increase its interest in Moleculon's voting stock to 70%.

F.H. Faulding & Co., an Australian pharmaceuticals company, said its Moleculon Inc. affiliate acquired Kalipharma Inc. for $ 23 million. Kalipharma is a New Jersey-based pharmaceuticals concern that sells products under the Purepac label. Faulding said it owns 33% of Moleculon's voting stock and has an agreement to acquire an additional 19%. That stake, together with its convertible preferred stock holdings, gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.